| 2922.49.40 | 20 | Glycine (Aminoacetic acid) | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ¢/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2922.50 | | Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: | | | | |
| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-¢/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ¢/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4¢/kg + 50% |
| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39% |
| 2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (¢/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 50% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2924.29.01 | 00 | p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamide | kg | Free | | 15.4¢/kg + 39.5% |
| 2924.29.10 | 00 | Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)aniline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2¢/kg + 3.3% (SG) | 15.4¢/kg + 58% |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 53% |
| 2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4¢/kg + 58% |
| 2924.29.26 | 00 | 3-Aminomethoxybenzanilide | kg | Free | | 15.4¢/kg + 54.5% |
| 2924.29.28 | 00 | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6- difluorobenzamide; and 3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)- benzamide (Pronamide) | kg | Free | | 15.4¢/kg + 64.5% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-¢/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
| 2924.29.43 | 00 | 3-Ethoxycarbonylaminophenyl-¢/phenylcarbamate (Desmedipham); and Isopropyl-N-(3-chlorophenyl)car- bamate (CIPC) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 40.5% |
| 2924.29.57 | 00 | Diethylaminoacetoxylidide (Lidocaine) | kg | Free | | 15.4¢/kg + 101.5% |
| 2924.29.62 | 10 | Acetaminophen | kg | | | |
| 2924.29.71 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
| 2924.29.76 | 30 | p-Aminobenzamide | kg | | | |
Harmonized Tariff Schedule of the United States inquiry: gaming
